Your session is about to expire
← Back to Search
Alcohol administration for Suicidal Ideation
Study Summary
This trial is testing the hypothesis that people who are intoxicated and in a negative mood are more likely to focus on suicide-related cues, which increases their risk for suicide. They will be testing this by administering alcohol to subjects and then inducing a negative or positive mood, followed by a performance-based task measuring attention towards suicide-related cues.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there openings available to participants in this trial?
"According to the latest information posted on clinicaltrials.gov, this trial is actively recruiting participants who meet certain criteria. It was first announced on March 10th 2022 and has recently been updated as of November 29th 2022."
Who can participate in this medical experiment?
"This trial is recruiting 120 participants, aged 21-65, with suicidal ideations. In addition to meeting the specified age range, applicants must be literate in English and have imbibed a minimum of five drinks per occasion on at least three occasions over the past year; four or more for female subjects."
To what medical conditions is alcohol typically prescribed?
"Ethanol administration is regularly employed to treat obstructive hypertrophic cardiomyopathy as well as communicable illnesses, ethylene glycol exposure and skin disinfection therapies."
What is the cap on participants for this clinical trial?
"Affirmative. Information hosted on clinicaltrials.gov confirms that recruitment is in progress for this medical trial, initially published on March 10th 2022 and recently amended November 29th 2022. A total of 120 patients must be enlisted from one site."
Can individuals aged 80 and above participate in this clinical experiment?
"According to the study's requirements, prospective participants must be at least 21 years of age and no older than 65."
Share this study with friends
Copy Link
Messenger